Medicskin Holdings Limited (8307.HK)
HKD 0.19
(1.6%)
HKD 0.19
(1.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.77 Million HKD | -17.94% |
| 2022 | 6.4 Million HKD | -51.25% |
| 2021 | 14.54 Million HKD | 32.79% |
| 2020 | 11.61 Million HKD | 86.25% |
| 2019 | 5.97 Million HKD | -67.44% |
| 2018 | -4.45 Million HKD | -19.18% |
| 2017 | 22.17 Million HKD | -2.24% |
| 2016 | 22.68 Million HKD | 296.12% |
| 2015 | 19.63 Million HKD | -68.26% |
| 2014 | 17.47 Million HKD | -37.41% |
| 2013 | 23.64 Million HKD | 45.94% |
| 2012 | 19.74 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 2.02 Million HKD | -17.48% |
| 2023 FY | - HKD | -17.94% |
| 2023 Q2 | 914 Thousand HKD | -54.77% |
| 2023 Q3 | -188 Thousand HKD | -120.57% |
| 2023 Q4 | -188 Thousand HKD | 0.0% |
| 2022 FY | - HKD | -51.25% |
| 2022 Q2 | 21 Thousand HKD | -98.85% |
| 2022 Q4 | 2.44 Million HKD | -6.28% |
| 2022 Q3 | 2.61 Million HKD | 12342.86% |
| 2022 Q1 | 1.83 Million HKD | -47.4% |
| 2021 FY | - HKD | 32.79% |
| 2021 Q3 | 3.98 Million HKD | 38.95% |
| 2021 Q4 | 3.48 Million HKD | -12.55% |
| 2021 Q1 | 4.08 Million HKD | 2304.71% |
| 2021 Q2 | 2.86 Million HKD | -29.84% |
| 2020 Q1 | 3.04 Million HKD | 670.73% |
| 2020 Q2 | 3.79 Million HKD | 24.65% |
| 2020 Q3 | 4.04 Million HKD | 6.78% |
| 2020 Q4 | 170 Thousand HKD | -95.8% |
| 2020 FY | - HKD | 86.25% |
| 2019 Q1 | 2.15 Million HKD | -48.48% |
| 2019 Q4 | -533 Thousand HKD | -124.38% |
| 2019 Q3 | 2.18 Million HKD | 0.88% |
| 2019 Q2 | 2.16 Million HKD | 0.37% |
| 2019 FY | - HKD | -67.44% |
| 2018 Q2 | 4.21 Million HKD | -4.73% |
| 2018 FY | - HKD | -19.18% |
| 2018 Q4 | 4.19 Million HKD | -16.11% |
| 2018 Q3 | 4.99 Million HKD | 18.56% |
| 2018 Q1 | 4.42 Million HKD | -23.15% |
| 2017 Q1 | 5.73 Million HKD | -5.91% |
| 2017 Q3 | 5.4 Million HKD | 2.25% |
| 2017 Q2 | 5.28 Million HKD | -7.85% |
| 2017 FY | - HKD | -2.24% |
| 2017 Q4 | 5.75 Million HKD | 6.55% |
| 2016 Q4 | 6.09 Million HKD | 0.56% |
| 2016 FY | - HKD | 296.12% |
| 2016 Q3 | 6.05 Million HKD | 14.6% |
| 2016 Q2 | 5.28 Million HKD | -42.01% |
| 2016 Q1 | 9.11 Million HKD | 906.07% |
| 2015 Q4 | 906 Thousand HKD | -50.27% |
| 2015 Q2 | 1.02 Million HKD | -79.3% |
| 2015 Q3 | 1.82 Million HKD | 78.28% |
| 2015 FY | - HKD | -68.26% |
| 2015 Q1 | 4.93 Million HKD | -12.35% |
| 2014 Q4 | 5.63 Million HKD | 47.72% |
| 2014 FY | - HKD | -37.41% |
| 2014 Q3 | 3.81 Million HKD | 176.18% |
| 2014 Q2 | 1.38 Million HKD | -72.44% |
| 2014 Q1 | 5.01 Million HKD | -3.09% |
| 2013 Q4 | 5.17 Million HKD | -41.74% |
| 2013 Q3 | 8.87 Million HKD | 0.0% |
| 2013 FY | - HKD | 45.94% |
| 2012 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 68.84 Million HKD | 90.158% |
| UMP Healthcare Holdings Limited | 161.98 Million HKD | 95.817% |
| Human Health Holdings Limited | 104.06 Million HKD | 93.489% |
| EuroEyes International Eye Clinic Limited | 292.1 Million HKD | 97.68% |
| Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | 94.929% |
| Bamboos Health Care Holdings Limited | 52.75 Million HKD | 87.156% |
| Beijing Health (Holdings) Limited | -44.19 Million HKD | 115.333% |
| C-MER Eye Care Holdings Limited | 359.88 Million HKD | 98.117% |
| Town Health International Medical Group Limited | 53.5 Million HKD | 87.335% |
| Hang Chi Holdings Limited | 81.58 Million HKD | 91.695% |